Commentary on 'Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose' by Jie Huang et al.
Br J Clin Pharmacol
; 90(9): 2320-2322, 2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-38922996
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Therapeutic Equivalency
/
Acarbose
/
Hypoglycemic Agents
Limits:
Humans
Language:
En
Journal:
Br J Clin Pharmacol
/
Br. j. clin. pharmacol
/
British journal of clinical pharmacology
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: